2023
DOI: 10.1186/s12883-023-03485-z
|View full text |Cite
|
Sign up to set email alerts
|

Non-pharmacological therapy for chemotherapy-induced peripheral neurotoxicity: a network meta-analysis of randomized controlled trials

Xia Zhang,
Ao Wang,
Miaowei Wang
et al.

Abstract: Background Chemotherapy-induced peripheral neurotoxicity (CIPN) is the most common adverse effect in patients undergoing chemotherapy, and no effective interventions are currently available for its prevention and treatment. Non-pharmacological therapies appear to be beneficial for the prevention and treatment of CIPN, but it remains unclear which therapy is most effective. The aim of this study was to identify the most effective non-pharmacological therapy for CIPN patients. … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 63 publications
0
1
0
Order By: Relevance
“…In our search, this is the first NMA study comparing different types of exercise interventions for CIPN, but the diversity of trials and outcomes could include bias. An RCT directly comparing balance training, strength training, and stretching resulted in different outcomes that showed efficacy ( 49 ); an NMA that suggested the efficacy of non-pharmacological interventions for CIPN also showed bias due to variability in trial setting ( 50 ).…”
Section: Discussionmentioning
confidence: 99%
“…In our search, this is the first NMA study comparing different types of exercise interventions for CIPN, but the diversity of trials and outcomes could include bias. An RCT directly comparing balance training, strength training, and stretching resulted in different outcomes that showed efficacy ( 49 ); an NMA that suggested the efficacy of non-pharmacological interventions for CIPN also showed bias due to variability in trial setting ( 50 ).…”
Section: Discussionmentioning
confidence: 99%